DEVICE · Unmapped registry intervention
"MAGSTIM" Repetitive transcranial magnetic stimulator (rTMS) system
Find medicine records ·
Find other trials using this name
Clinical trial
Supplementary Motor Area is a Potential Target for Speech Disturbance in Parkinson Disease
NCT05478057
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSupplementary Motor Area is a Potential Target for Speech Disturbance in Parkinson Disease
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson Diseaseverified · MONDO: Parkinson disease
Interventions
Sponsors & collaborators
Chang Gung Memorial Hospitallead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05478057 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.